Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes

CONCLUSION: This large study confirms the beneficial effect of ESAs and the adverse effect of somatic mutations in patients with LR-MDS.PMID:38186638 | PMC:PMC10768603 | DOI:10.1177/20406207231218157

Source: Adv Data - January 8, 2024 Category: Epidemiology Authors: Juan Carlos Caballero Julio D ávila Mar ía López-Pavía Esperanza Such Teresa Bernal Fernando Ramos Marisa Calabuig Jes ús María Hernández Sánchez Helena Pomares Mercedes S ánchez Barba Mar ía Abáigar Bernardo Gonz ález Brayan Merch án Reyes S Source Type: research